Decibel Therapeutics, Inc. (DBTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Add to watchlist

Visitors trend2W10W9M

4.1200

-0.0900

(-2.14%)

At close: 04:00PM EDT

4.2900

+0.17

(+4.13%)

After hours:

07:57PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Bullishpattern detected

Short-term KST

View all chart patterns

Performance Outlook

Previous Close	4.2100
Open	4.2100
Bid	4.1100 x 1400
Ask	4.3000 x 1000
Day's Range	3.9200 - 4.5200
52 Week Range	1.8310 - 9.7500
Volume	664,231
Avg. Volume	258,219

Market Cap	102.854M
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	-2.2030
Earnings Date	Aug 08, 2022 - Aug 12, 2022
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	16.00

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for DBTX

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

Decibel Therapeutics, Inc.
Daily – Vickers Top Insider Picks for 06/28/2022The Vickers Top Insider Picks is a daily report that utilizes a proprietary algorithm to identify 25 companies with compelling insider purchase histories based on transactions over the past three months.
Rating
Fair Value
Economic Moat
4 days agoArgus Research

All

Simply Wall St.
Could The Decibel Therapeutics, Inc. (NASDAQ:DBTX) Ownership Structure Tell Us Something Useful?
A look at the shareholders of Decibel Therapeutics, Inc. ( NASDAQ:DBTX ) can tell us which group is most powerful...
- Here's What Alphatec Holdings, Inc.'s (NASDAQ:ATEC) Shareholder Ownership Structure Looks Like
  Simply Wall St.
- What Is The Ownership Structure Like For Arena Fortify Acquisition Corp. (NASDAQ:AFAC)?
  Simply Wall St.
GlobeNewswire
Decibel Therapeutics Reports Positive Data from Interim Analysis of Ongoing Phase 1b Clinical Trial of DB-020 in Patients Receiving Cisplatin Chemotherapy
- 87% of patients who experienced ototoxicity in their placebo-treated ear were protected from ototoxicity in their DB-020-treated ear – - Data support continued development of DB-020 as a potential therapy to protect against hearing loss in patients receiving cisplatin chemotherapy for cancer – - Management will review results during a webcast today at 8:00 a.m. EDT - BOSTON, June 28, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated
GlobeNewswire
Decibel Therapeutics to Present at the Jefferies Global Healthcare Conference
BOSTON, June 03, 2022 (GLOBE NEWSWIRE) -- Decibel Therapeutics (Nasdaq: DBTX), a clinical-stage biotechnology company dedicated to discovering and developing transformative treatments to restore and improve hearing and balance, today announced that John Lee, chief development officer, and Lis Leiderman, M.D., MBA, chief financial officer, will participate in a fireside chat at the Jefferies Global Healthcare Conference on Friday, June 10, 2022 at 9:00 a.m. ET. A live webcast of the fireside chat